Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.33 USD | +3.85% | +4.81% | -1.22% |
Apr. 23 | Buy now, pay later lender Affirm pushes into elective medical procedures | RE |
Apr. 15 | Weave Now Integrates with Shepherd | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 975.2 | 300.4 | 796.9 | 804.2 | - | - |
Enterprise Value (EV) 1 | 864.2 | 248.4 | 688 | 717.8 | 705.8 | 707.5 |
P/E ratio | -5.84 x | -6.03 x | -24.9 x | -28.2 x | -35.9 x | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 8.42 x | 2.11 x | 4.67 x | 4.1 x | 3.56 x | 3.25 x |
EV / Revenue | 7.46 x | 1.75 x | 4.04 x | 3.66 x | 3.13 x | 2.86 x |
EV / EBITDA | -26 x | -9.67 x | -87.7 x | -1,467 x | 82.9 x | - |
EV / FCF | -28.6 x | -16.9 x | 105 x | 71.3 x | 39.2 x | - |
FCF Yield | -3.49% | -5.9% | 0.95% | 1.4% | 2.55% | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 64,240 | 65,582 | 69,474 | 70,980 | - | - |
Reference price 2 | 15.18 | 4.580 | 11.47 | 11.33 | 11.33 | 11.33 |
Announcement Date | 3/2/22 | 2/22/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | 115.9 | 142.1 | 170.5 | 196.3 | 225.6 | 247.4 |
EBITDA 1 | -33.27 | -25.69 | -7.846 | -0.4891 | 8.515 | - |
EBIT 1 | -36.3 | -30.95 | -11.54 | -3.861 | 4.85 | 13.11 |
Operating Margin | -31.33% | -21.78% | -6.77% | -1.97% | 2.15% | 5.3% |
Earnings before Tax (EBT) 1 | -51.63 | -49.63 | -30.77 | -29 | -24.36 | -15.94 |
Net income 1 | -53.65 | -49.74 | -31.03 | -28.61 | -23.94 | - |
Net margin | -46.3% | -35% | -18.2% | -14.58% | -10.61% | - |
EPS 2 | -2.600 | -0.7600 | -0.4600 | -0.4020 | -0.3160 | - |
Free Cash Flow 1 | -30.18 | -14.66 | 6.531 | 10.06 | 18.02 | - |
FCF margin | -26.05% | -10.32% | 3.83% | 5.13% | 7.98% | - |
FCF Conversion (EBITDA) | - | - | - | - | 211.57% | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - |
Announcement Date | 3/2/22 | 2/22/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 30.3 | 31.84 | 33.27 | 34.93 | 36.23 | 37.68 | 39.56 | 41.67 | 43.54 | 45.69 | 45.79 | 48.21 | 50.06 | 52.21 | 53.54 |
EBITDA 1 | -9.104 | -9.682 | -9.123 | -9.019 | -5.155 | -2.388 | -1.963 | -3.032 | -0.911 | -0.789 | -1.117 | -0.6713 | 0.2511 | 1.048 | 0.994 |
EBIT 1 | -9.959 | -10.6 | -10.08 | -10.11 | -6.536 | -4.22 | -4.005 | -3.957 | -1.835 | -1.746 | -1.903 | -1.461 | -0.603 | 0.1059 | 0.192 |
Operating Margin | -32.87% | -33.3% | -30.31% | -28.95% | -18.04% | -11.2% | -10.12% | -9.5% | -4.21% | -3.82% | -4.16% | -3.03% | -1.2% | 0.2% | 0.36% |
Earnings before Tax (EBT) 1 | -14.8 | -14.02 | -13.81 | -14.8 | -11.79 | -9.244 | -7.839 | -8.939 | -7.066 | -6.927 | -7.356 | -7.392 | -6.666 | -6.188 | -6.974 |
Net income 1 | -14.8 | -14.34 | -13.84 | -14.82 | -11.82 | -9.266 | -7.859 | -8.988 | -7.145 | -7.039 | -7.672 | -7.589 | -6.933 | -6.417 | -6.634 |
Net margin | -48.86% | -45.03% | -41.59% | -42.41% | -32.62% | -24.59% | -19.86% | -21.57% | -16.41% | -15.41% | -16.76% | -15.74% | -13.85% | -12.29% | -12.39% |
EPS 2 | -1.030 | -0.3400 | -0.2100 | -0.2300 | -0.1800 | -0.1400 | -0.1200 | -0.1300 | -0.1000 | -0.1000 | -0.1100 | -0.1080 | -0.0960 | -0.0880 | -0.0900 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 12/7/21 | 3/2/22 | 5/4/22 | 8/3/22 | 11/2/22 | 2/22/23 | 5/3/23 | 8/2/23 | 11/1/23 | 2/21/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 111 | 52 | 109 | 86.4 | 98.4 | 96.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -30.2 | -14.7 | 6.53 | 10.1 | 18 | - |
ROE (net income / shareholders' equity) | - | -31.7% | -10.1% | -6.82% | 6.61% | 10.8% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share 2 | -0.9900 | -0.2000 | 0.1500 | 0.3300 | 0.5300 | - |
Capex 1 | 7.38 | 1.9 | 1.69 | 2.46 | 2.59 | - |
Capex / Sales | 6.37% | 1.33% | 0.99% | 1.25% | 1.15% | - |
Announcement Date | 3/2/22 | 2/22/23 | 2/21/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.22% | 804M | |
+8.05% | 3,020B | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
+31.16% | 50.15B | |
-24.56% | 46.71B | |
+17.75% | 41.41B | |
+55.21% | 36.1B | |
-10.24% | 24.64B |
- Stock Market
- Equities
- WEAV Stock
- Financials Weave Communications, Inc.